RE: RE: RE: RE: AGM comin up next Friday.. Bet Int Thanks JD and Minib..both insightful... note, i never said they WOULD, i merely said they COULD.
I've tried to guess management's motivations for doing what they've done thus far and have been wrong.. all i am saying is it is a possibility. Endpoint data is different than what would be released if they WERE to include any sort of efficacy.
"Endpoint data"| is the data gained at the end of the 8 month treatment, in addition to the 4 month follow up after treatment is completed. There would be zero endpoint data at this point; though there would be PLENTY of basic efficacy observations that COULD be included at this point; if again, management CHOSE TO.
either way, all i am saying is it is a possibility and we will all soon find out in 4 trading days from now.
Note, I believe minib you conceded that in fact it was possible for management to release such data if they chose to based on your last post... though if you or anyone else wants further clarifications as to whether it is a possibility i emplore you to simply Google the phrase "Interim phase 2 efficacy" ....; where you will see COUNTLESS other company releases.